ca-ssis / iStockphoto.com
16 January 2019Americas
FDA announces new measures to boost gene therapy innovation
The US Food and Drug Administration (FDA) has announced new policies to advance the development of safe and effective cell and gene therapies.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Biotechnology
13 December 2018 The US Food and Drug Administration has announced new measures to advance the development of biosimilar medicines.
Americas
31 January 2019 A record number of novel devices were approved by the US Food and Drug Administration in 2018, the federal agency has said.
Editor's picks
Editor's picks
Biotechnology
13 December 2018 The US Food and Drug Administration has announced new measures to advance the development of biosimilar medicines.
Americas
31 January 2019 A record number of novel devices were approved by the US Food and Drug Administration in 2018, the federal agency has said.
Biotechnology
13 December 2018 The US Food and Drug Administration has announced new measures to advance the development of biosimilar medicines.
Americas
31 January 2019 A record number of novel devices were approved by the US Food and Drug Administration in 2018, the federal agency has said.